The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $66.69

Today's change-0.53 -0.79%
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $66.69

Today's change-0.53 -0.79%
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.

ResMed Inc down (U.S.)$0.53

ResMed Inc closed lower Wednesday, dropping (U.S.)$0.53 or 0.79% to (U.S.)$66.69. Shares have lost 1.93% over the last five days, but have gained 24.21% over the last year to date. This security has outperformed the S&P 500 by 18.32% during the last year.

Key company metrics

  • Open(U.S.) $67.25
  • Previous close(U.S.) $67.22
  • High(U.S.) $67.62
  • Low(U.S.) $66.68
  • Bid / Ask-- / --
  • YTD % change+24.21%
  • Volume783,454
  • Average volume (10-day)1,227,635
  • Average volume (1-month)988,785
  • Average volume (3-month)916,966
  • 52-week range(U.S.) $49.11 to (U.S.) $70.90
  • Beta0.71
  • Trailing P/E26.78×
  • P/E 1 year forward23.38×
  • Forward PEG2.24×
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield1.98%
  • Trailing EPS(U.S.) $2.49
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.59%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue519454455412
Total other revenue--------
Total revenue519454455412
Gross profit301260267239
Total cost of revenue217194188173
Total operating expense400350347314
Selling / general / administrative136123118111
Research & development34282927
Depreciation / amortization13542
Interest expense (income), net operating--------
Unusual expense (income)007--
Other operating expenses, total--------
Operating income11910410898
Interest income (expense), net non-operating-11------
Gain (loss) on sale of assets--------
Other--------
Income before tax11710911499
Income after tax93889180
Income tax, total24212319
Net income93889180
Total adjustments to net income--------
Net income before extra. items93889180
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items93889180
Inc. avail. to common incl. extra. items93889180
Diluted net income93889180
Dilution adjustment0------
Diluted weighted average shares142141141142
Diluted EPS excluding extraordinary itemsvalue per share0.660.630.640.57
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share0.660.630.680.57